J.Á. Cuesta Alcalá

ORCID: 0000-0003-3455-4880
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Urological Disorders and Treatments
  • Pediatric Urology and Nephrology Studies
  • Prostate Cancer Diagnosis and Treatment
  • Urinary Bladder and Prostate Research
  • Renal and related cancers
  • Urologic and reproductive health conditions
  • Vascular anomalies and interventions
  • Smoking Behavior and Cessation
  • Urinary and Genital Oncology Studies
  • Renal and Vascular Pathologies
  • Pituitary Gland Disorders and Treatments
  • Ureteral procedures and complications
  • Adrenal and Paraganglionic Tumors
  • Schizophrenia research and treatment
  • Cancer Genomics and Diagnostics
  • Renal cell carcinoma treatment
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Inflammatory Myopathies and Dermatomyositis
  • Muscle and Compartmental Disorders
  • Skin Diseases and Diabetes
  • E-Learning and Knowledge Management
  • Information Architecture and Usability
  • Abdominal Surgery and Complications
  • Infectious Disease Case Reports and Treatments
  • Electroconvulsive Therapy Studies

Hospital Universitario Reina Sofía
2010-2024

Instituto Maimónides de Investigación Biomédica de Córdoba
2021

Universidad de Navarra
2001-2007

Hospital de l'Esperança
2002

Toyota Central Research and Development Laboratories (Japan)
1998

Hospital Británico
1995

One of the big challenges in treating individuals with bipolar disorder (BD) is nonadherence to medication. This principal factor associated a worse prognosis or outcome disease. study aimed explore and analyze individual perceptions that people BD have about positive negative aspects when taking A descriptive interpretative was carried out using qualitative research paradigm use analytical technique discourse analysis, extracting data through completion focus groups. Participants' speech...

10.3390/ijerph19137633 article EN International Journal of Environmental Research and Public Health 2022-06-22

This study has two main objectives: to describe the prevalence of undetected chronic obstructive pulmonary disease (COPD) in a clinical sample smokers with severe mental illness (SMI), and assess value Tobacco Intensive Motivational Estimated Risk tool, which informs their respiratory risk uses brief text messages reinforce intervention.A multicenter, randomized, open-label, active-controlled trial, 12-month follow-up. Outpatients schizophrenia (SZ) bipolar disorder were randomized either...

10.1192/j.eurpsy.2021.12 article EN cc-by-nc-nd European Psychiatry 2021-01-01

Tobacco consumption is the main preventable factor of mortality in smokers with bipolar disorder (BD), and any possible solutions are often blocked by prejudices over desire, possibilities risks for these patients giving up tobacco consumption. Adults BD were recruited at 8 Mental Health Centres. Smokers evaluated before after a brief intervention based on 3 A's classified into 'Stage Change' (SOC) their 'Readiness to (RTC). A multiple linear regression was used analyze progression RTC...

10.20882/adicciones.1006 article EN Adicciones 2018-07-13

There is an increased risk of premature death in people with severe mental illness (SMI). Respiratory disorders and cardiovascular disease are leading causes mortality rates these patients, tobacco consumption remains the most preventable factor involved. Developing new tools to motivate patients towards cessation smoking a high priority. Information on motivational value giving lung age prevention opportunities unknown this high-risk population. This article describes detail protocol...

10.1186/s13063-018-3139-9 article EN cc-by Trials 2019-01-14

PROSTATECTOMÍA RADICAL LAPAROSCÓPICA.¿SÓLO EN CENTROS DE EXCELENCIA?Objetivos: Presentar la experiencia adquirida en técnica de prostatectomía radical laparoscópica un hospital general con área influencia 200.000 habitantes, analizando los resultados preliminares nuestra serie.Material y Métodos: Entre diciembre 2002 agosto 2005 se seleccionaron total 26 pacientes para laparoscópica, 25 vía transperitoneal 1 extraperitoneal.La edad media fue 62,3 ± 5,3 años (rango 52-69).El PSA medio 9,16...

10.4321/s0210-48062005001000003 article ES cc-by-nc Actas Urológicas Españolas 2005-12-01
Coming Soon ...